Fortis Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Sell |
5,176
-774
| -13% | -$64.2K | 0.27% | 68 |
|
|
2025
Q1 | $483K | Hold |
5,950
| – | – | 0.31% | 60 |
|
|
2024
Q4 | $536K | Buy |
5,950
+650
| +12% | +$58.5K | 0.35% | 52 |
|
|
2024
Q3 | $524K | Hold |
5,300
| – | – | 0.34% | 54 |
|
|
2024
Q2 | $491K | Buy |
5,300
+1,150
| +28% | +$107K | 0.35% | 45 |
|
|
2024
Q1 | $394K | Hold |
4,150
| – | – | 0.26% | 61 |
|
|
2023
Q4 | $371K | Hold |
4,150
| – | – | 0.26% | 61 |
|
|
2023
Q3 | $303K | Hold |
4,150
| – | – | 0.23% | 71 |
|
|
2023
Q2 | $345K | Hold |
4,150
| – | – | 0.25% | 63 |
|
|
2023
Q1 | $316K | Hold |
4,150
| – | – | 0.21% | 68 |
|
|
2022
Q4 | $344K | Hold |
4,150
| – | – | 0.26% | 62 |
|
|
2022
Q3 | $329K | Buy |
4,150
+500
| +14% | +$39.6K | 0.23% | 65 |
|
|
2022
Q2 | $271K | Buy |
3,650
+650
| +22% | +$48.3K | 0.18% | 77 |
|
|
2022
Q1 | $270K | Buy |
+3,000
| New | +$270K | 0.15% | 84 |
|